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ABSTRACT
Chronic lymphocytic leukemia (CLL) is a malignant, low-grade, monoclonal disorder characterized by the accumulation of lymphocytes with variable 
clinical features. Cutaneous manifestations or leukemia cutis are non-specific, uncommon presentations of CLL and can present in many different 
ways. In this case report, we discuss a 76-year-old male who presented with skin lesions of the lower limbs and severe itching. Due to the lack of 
response to the treatment with topical corticosteroids, initial tests were carried out. Complete blood count results indicated lymphocytosis. Eventually 
Ultimately, the skin lesions led to the diagnosis of CLL. The patient was treated with bendamustine-rituximab (BR). After receiving the treatment, all 
cutaneous manifestations and generalized itching disappeared. This case highlights the importance of comparing similar cases of CLL presented with 
dermatological conditions in order to to understand proper management and practice.
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INTRODUCTION
Chronic lymphocytic leukemia (CLL) which is the most common form 
of leukemia is a low-grade lymphoproliferative disorder. Clinical 
presentations of CLL can be a variable spectrum of features [1]. 
Although CLL usually presents with classic manifestations, in some 
cases, it appears with unusual or rare externalizations [2]. Cutaneous 
manifestations and skin lesions which are called leukemia cutis are rare 
presentations of CLL and occur in 4–25% of patients and usually do 
not appear as the first sign of the disease [3]. In this case, we report a 
patient with CLL who has presented with a flat skin lesion, erythema, 
and severe itching.
CASE REPORT
A 76-year-old man with a medical history of hypertension and no prior 
chemotherapy presented with flat lesions of the lower limbs and severe 
itching (Fig. 1). The patient was examined by a dermatologist 2 months 
before the admission and treated with topical corticosteroids and anti-
histamines. As a consequence of the lack of response to the treatment, 
initial tests were conducted.
Complete blood count test revealed WBC 18.67(*109 L), RBC 3.21 (*10 
12 L), hemoglobin 9.8 (g/dl), HCT 31.5%, and PLT 198 (*109 L). Blood 
differential test showed lymphocyte 90.8%, neutrophil 8.6%, monocyte 
0.4%, eosinophil 0.2%, and basophil 0.0%. Due to the lymphocytosis as 
the result of conducted tests, the patient was referred to a hematologist 
for further examinations.
Computed tomography scan indicated a few small lymph nodes on the 
base of the neck, significant adenopathy in the posterior triangle of the 
neck, adenopathy in the axillary regions, and mild splenomegaly with 
the length of 156 mm (Fig. 2).
To conduct a further examination, the biopsy of itching cutaneous 
lesions was carried out. Microscopical findings showed skin tissue with 
moderate perivascular lymphocytic aggregation and vessel damage. 
In conclusion, pathological studies of lesions indicated lymphocytic 
vasculitis.
Results of peripheral blood flow cytometry showed the percentage 
of reactivities of the cells with the MoAbs. CD20 was 71% as a B-cell 
marker, CD5 was 93% as a T-cell marker, CD23 was 77%, and CD 10 was 
reported negative.
Bone marrow aspiration and biopsy revealed an obvious increase in 
lymphoid proliferation (Fig. 3).
As the result of conducted tests and examinations, diagnosis of CLL was 
confirmed. According to the Rai staging system for CLL, our patient had 
Stage III CLL.
After confirmation of the diagnosis of CLL, the patient was treated with 
bendamustine-rituximab. The administered dose of rituximab was 
700 mg on the 1st day. On the 2nd and 3rd day, the administered dose of 
bendamustine was 150 mg.
The patient tolerated chemotherapy and 1 day after the first period of 
prescribed chemotherapy, the symptoms were improved and itching 
was resolved (Fig. 4).
The patient consent for using the information and images has been taken.
DISCUSSION
CLL is considered as the most common adult leukemia worldwide and 
among all leukemia in the United States, CLL accounts for 25–30% of 
cases [4].
Cutaneous eruptions and dermatological conditions in CLL have been 
identified in 4–25% of patients [3,5]. Cutaneous manifestations of CLL 
may be presented primarily as leukemia cutis or more commonly as 
secondary lesions [6].
Typical presentations of leukemia cutis in CLL are erythematous papules, 
plaques, nodules, or large tumors. According to the histopathological 
findings, cutaneous infiltrations in CLL can be described with three 
architectural patterns. These patterns are patchy perivascular and 
periadnexal, band-like, and nodular diffuse [7].
Case Report
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Although previous case reports suggested the notion that leukemia 
cutis leads to a negative prognosis, recent data and studies indicate that 
in the absence of progressed systemic disease, cutaneous involvement 
in CLL does not affect prognosis [8].
Similar cases of CLL with cutaneous manifestations has have been 
documented and reported. Lu et al. reported a patient with subclinical 
B-cell CLL presented with skin hypertrophic changes of the ears, 
eyebrows, tip of the nose, toes, and fingers. According to this case 
report, considering leukemia cutis in patients with underlying CLL is 
important [9].
Another case reported by Raufi et al. who introduced a patient with the 
skin lesion of bilateral ears. This cutaneous manifestation led to the 
diagnosis of CLL [10].
This case, by describing a flat skin lesion with erythema and severe 
itching of the lower limb as an unusual clinical manifestation of CLL, 
highlights the importance of considering leukemia cutis as a harbinger 
of underlying CLL (Fig. 1).
Although our case suggests that early cutaneous manifestations of CLL 
can lead to the diagnosis. Further investigations and comparison of 
similar cases is are needed to enhance our understanding of disease as 
well as proper management and practice.
CONCLUSION
Cutaneous lesions which do not answer to the common treatments 
should be considered serious and to diagnose the main disorder and 
rule out the differential diagnosis further examinations should be ruled 
out.
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Fig. 1: Skin lesions of the lower limbs like flat lesions without 
papules or pustules
Fig. 2: Mild splenomegaly revealed by computed tomography scan
Fig. 3: Bone marrow aspiration reveals increase in lymphoid 
proliferation [×1000]
Fig. 4: The conditions of skin lesions in the same areas after the 
first course of chemotherapy
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